We therefore hypothesize that in MPTP-induced PD model mice, MAP6 glycosylated with Gal-(β-1,3)-GalNAc may damage the neurons in the nigrostriatal dopaminergic pathway, ultimately disrupting dopaminergic neurotransmission. Here, MAP6 is linked to Parkinson disease.